Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin-based Regimens for H. Pylori in Syria
NCT06065267Phase 4Not yet recruiting
- Sponsor
- Damascus Hospital
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Helicobacter pylori infection, sponsored by Damascus Hospital. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06065267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06065267.